These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Galectin-3, a novel binding partner of beta-catenin. Shimura T, Takenaka Y, Tsutsumi S, Hogan V, Kikuchi A, Raz A. Cancer Res; 2004 Sep 15; 64(18):6363-7. PubMed ID: 15374939 [Abstract] [Full Text] [Related]
5. Beta-catenin-related anomalies in apoptosis-resistant and hormone-refractory prostate cancer cells. de la Taille A, Rubin MA, Chen MW, Vacherot F, de Medina SG, Burchardt M, Buttyan R, Chopin D. Clin Cancer Res; 2003 May 15; 9(5):1801-7. PubMed ID: 12738737 [Abstract] [Full Text] [Related]
7. Isolation of a novel human gene, APCDD1, as a direct target of the beta-Catenin/T-cell factor 4 complex with probable involvement in colorectal carcinogenesis. Takahashi M, Fujita M, Furukawa Y, Hamamoto R, Shimokawa T, Miwa N, Ogawa M, Nakamura Y. Cancer Res; 2002 Oct 15; 62(20):5651-6. PubMed ID: 12384519 [Abstract] [Full Text] [Related]
8. Cross-talk between Rac1 GTPase and dysregulated Wnt signaling pathway leads to cellular redistribution of beta-catenin and TCF/LEF-mediated transcriptional activation. Esufali S, Bapat B. Oncogene; 2004 Oct 28; 23(50):8260-71. PubMed ID: 15377999 [Abstract] [Full Text] [Related]
9. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T, Nakagawa H. Biochem Biophys Res Commun; 2001 Oct 19; 288(1):8-15. PubMed ID: 11594745 [Abstract] [Full Text] [Related]
10. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis. Mulholland DJ, Read JT, Rennie PS, Cox ME, Nelson CC. Oncogene; 2003 Aug 28; 22(36):5602-13. PubMed ID: 12944908 [Abstract] [Full Text] [Related]
11. Cleavage of beta-catenin by calpain in prostate and mammary tumor cells. Rios-Doria J, Kuefer R, Ethier SP, Day ML. Cancer Res; 2004 Oct 15; 64(20):7237-40. PubMed ID: 15492240 [Abstract] [Full Text] [Related]
12. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, Birembaut P. Cancer Res; 2005 Sep 01; 65(17):7691-8. PubMed ID: 16140936 [Abstract] [Full Text] [Related]
13. Rare activation of the TCF/beta-catenin pathway in ovarian cancer. Furlong MT, Morin PJ. Gynecol Oncol; 2000 Apr 01; 77(1):97-104. PubMed ID: 10739697 [Abstract] [Full Text] [Related]
15. Down-regulation of monocyte chemotactic protein-3 by activated beta-catenin. Fujita M, Furukawa Y, Nagasawa Y, Ogawa M, Nakamura Y. Cancer Res; 2000 Dec 01; 60(23):6683-7. PubMed ID: 11118053 [Abstract] [Full Text] [Related]
18. Down-regulation of beta-catenin TCF signaling is linked to colonic epithelial cell differentiation. Mariadason JM, Bordonaro M, Aslam F, Shi L, Kuraguchi M, Velcich A, Augenlicht LH. Cancer Res; 2001 Apr 15; 61(8):3465-71. PubMed ID: 11309309 [Abstract] [Full Text] [Related]
19. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis. Yamada T, Takaoka AS, Naishiro Y, Hayashi R, Maruyama K, Maesawa C, Ochiai A, Hirohashi S. Cancer Res; 2000 Sep 01; 60(17):4761-6. PubMed ID: 10987283 [Abstract] [Full Text] [Related]